Breaking News
March 21, 2019 - Smell of skin could lead to early diagnosis for Parkinson’s
March 21, 2019 - Difference in brain connectivity may explain autism spectrum disorder
March 21, 2019 - Untangling the microbiome — with statistics
March 21, 2019 - Human microbiome metabolites enhance colon injury by enterohemorrhagic E. coli, study shows
March 21, 2019 - Written media can improve citizens’ understanding of palliative care
March 21, 2019 - New research aims to find how asthma symptoms are aggravated
March 21, 2019 - New $9.7 million NIH grant project seeks to improve hearing restoration
March 21, 2019 - Researchers measure brain metabolite levels in people with mild memory problems
March 21, 2019 - FDA approves first drug for treatment of postpartum depression in adult women
March 20, 2019 - Gene editing and designer babies experiments face global moratorium
March 20, 2019 - Major scientific study of wound care dressings wins ‘Best Clinical or Preclinical Research Award’
March 20, 2019 - Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
March 20, 2019 - Big data study identifies drugs that increase risk of psychosis in youth with ADHD
March 20, 2019 - Mystery novel and dream spur key scientific insight into heart defect | News Center
March 20, 2019 - Study measures impact of policies designed to reduce air pollution in two mega-cities
March 20, 2019 - Mild sleep apnea during pregnancy changes sugar levels and may affect infant growth patterns
March 20, 2019 - SSB and Novasep collaborate to develop new membrane chromatography systems
March 20, 2019 - Leaky valve repair improves quality of life in heart failure patients
March 20, 2019 - Diattenuation Imaging offers structural information of difficult to access brain regions
March 20, 2019 - Early sports specialization linked to increased injury rates during athletic career
March 20, 2019 - Study brings clarity about milk intake for children with Duarte galactosemia
March 20, 2019 - Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
March 20, 2019 - Maternal smoking during pregnancy increases risk of ADHD among offspring up to three-fold
March 20, 2019 - Pioneering pediatric kidney transplant surgeon Oscar Salvatierra dies at 83 | News Center
March 20, 2019 - F.D.A. Approves First Drug for Postpartum Depression
March 20, 2019 - TB remains a major public health challenge in the European region
March 20, 2019 - Most pills contain common allergens, warn experts
March 20, 2019 - Researchers discover previously unknown mechanism by which cells can sense oxygen
March 20, 2019 - World’s leading source of data on diagnosis, treatments for aortic dissection
March 20, 2019 - Breast cancer relapse predictor may soon be a reality
March 20, 2019 - Researchers identify origin of chronic pain in humans
March 20, 2019 - Two-drug combinations containing calcium channel blocker significantly lowers BP
March 20, 2019 - King’s scientists to monitor air quality exposure of 250 children
March 20, 2019 - Preventative cardioverter defibrillator implantation is of little benefit to kidney dialysis patients
March 20, 2019 - New method based on neurofeedback may reduce anxiety
March 20, 2019 - Study explores whether alcohol consumption can have an effect on arthritis
March 20, 2019 - Merck to collaborate with GenScript for plasmid and virus manufacturing in China
March 20, 2019 - FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
March 20, 2019 - Study examines long-term opioid use in patients with severe osteoarthritis
March 20, 2019 - Retired Stanford professor Edward Rubenstein, pioneer in intensive care medicine, dies at 94 | News Center
March 20, 2019 - Aaron Diamond AIDS Research Center to Join Columbia University
March 20, 2019 - Call for halt to human gene editing and designer babies experiments
March 20, 2019 - Study illuminates how hot spots of genetic variation evolved in the human genome
March 20, 2019 - Roundworm study suggests alternatives for treatment of schizophrenia
March 20, 2019 - Sphingotec reports new applications of bio-ADM at 39th ISICEM
March 20, 2019 - Preventing falls through free community-based screenings for older adults
March 20, 2019 - AAOS: Supplement Use Low in Patients With Osteoporosis, Hip Fracture
March 20, 2019 - Does intensive blood pressure control reduce dementia?
March 20, 2019 - Nut consumption could be key to better cognitive health in older people
March 20, 2019 - Drinking hot tea associated with increased risk of esophageal cancer
March 20, 2019 - Androgen receptor plays vital role in regulating multiple mitochondrial processes
March 20, 2019 - NIH announces funding boost for Detroit Cardiovascular Training Program
March 20, 2019 - Study reveals another surgical option for patients with irreparable rotator cuff tears
March 20, 2019 - New robot-guided video game may be effective and low-cost solution for caregivers
March 20, 2019 - Heart Attacks Fall By One-Third Among Older Americans
March 20, 2019 - Data sharing uncovers five new risk genes for Alzheimer’s disease
March 20, 2019 - Does It Make Sense To Delay Children’s Vaccines?
March 20, 2019 - Lack of health insurance may increase Aging immigrants’ risk for cardiovascular disease
March 20, 2019 - Piece of puzzle unlocked in what drives alcohol addiction
March 20, 2019 - Researchers investigate whether Zika reservoirs are found in the Americas
March 20, 2019 - Compounds found in coffee may inhibit growth of prostate cancer
March 20, 2019 - Lab Innovations returns to the NEC on 30 & 31 October 2019
March 20, 2019 - How genes affect tobacco and alcohol use
March 20, 2019 - Osteoarthritis and rheumatoid arthritis have similar impacts on patients
March 20, 2019 - Individuals with infection history have higher risk of developing Sjögren’s syndrome
March 20, 2019 - Nursing home residents benefit from individualized multi-component exercise program
March 20, 2019 - Plant cellulose bone implants are “viable” option to support new bone growth, study finds
March 20, 2019 - Older people living in retirement communities benefit from improved health
March 20, 2019 - UTSA professor helps train first responders to detect prescription opioid overdoses
March 20, 2019 - Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
March 20, 2019 - Smoking may limit body’s ability to fight dangerous form of skin cancer
March 20, 2019 - Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
March 20, 2019 - TGen and ABL sign agreement to distribute new TB test technology
March 20, 2019 - UCD researchers lead development of new urine test to detect prostate cancer
March 20, 2019 - Miniature brains that can move muscles, grown in the lab
March 20, 2019 - Servier and Oncodesign announce research and drug development partnership
March 20, 2019 - FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
March 20, 2019 - TB Medicine Pretomanid Enters Regulatory Review Process in the United States
March 20, 2019 - Breastfeeding can erase effects of prenatal violence for newborns
March 20, 2019 - Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
Mushrooms may fight neurodegeneration in later life

Mushrooms may fight neurodegeneration in later life

image_pdfDownload PDFimage_print

Research from a Singapore-based study has suggested that mild cognitive impairment could be prevented in people over the age of 60 by simply eating mushrooms more than twice a week.

Mushrooms may protect against mild cognitive impairment linked to old ageRubencress | Shutterstock

The National University of Singapore (NUS) carried out the cross-sectional study with support from the Life Sciences Institute and the Mind Science Centre at NUS, and the National Medical Research Council from the Singapore Ministry of Health. Assistant professor Lei Feng from the National University of Singapore’s department of psychological medicine led the study.

The study was based on data collected on the diets of 663 Chinese people over the age of 60. Their diet and lifestyles were tracked over a period of six years from 2011 to 2017.

A portion of mushrooms was defined as having an average weight of approximately 150 grams, with two portions being equal to half a plate. The mushrooms included in the study were golden, oyster, shiitake, white button mushrooms, and dried and canned mushrooms, as these are commonly consumed varities in Singapore.

Other mushroom varieties that were not included in the study may also harness the same benefits as the types included in the study.

The results, which have been published in the Journal of Alzheimer’s Disease, showed that consuming over two portions of cooked mushrooms a week decreased the risk of mild cognitive impairment by 50 percent, when compared with individuals who ate fewer than one portion a week.

Although the study emphasizes the effects of two or more portions of mushrooms per week, results also showed that one small portion per week could still contribute to decreasing the chances of mild cognitive impairment in advanced ages.

Mild cognitive impairment is defined as the stage between normal, age-related cognitive decline and the significant decline caused by dementia. Mild cognitive decline is characterized by memory loss or forgetfulness, and it may also present difficulties with language, attention, and visuospatial functions.

The effects of mild cognitive impairment do not manifest as clearly as those of dementia as they do not affect a person’s ability to carry out everyday activities as severely. Feng explains how the study accounted for this difference, saying:

People with MCI are still able to carry out their normal daily activities. So, what we had to determine in this study is whether these seniors had poorer performance on standard neuropsychologist tests than other people of the same age and education background.

Neuropsychological tests are specifically designed tasks that can measure various aspects of a person’s cognitive abilities. In fact, some of the tests we used in this study are adopted from commonly used IQ test battery, the Wechsler Adult Intelligence Scale (WAIS).”

Lei Feng, Lead Author

To make accurate diagnoses, the researchers carried out detailed interviews and tests. On the type of information gathered in these interviews, Feng said:

“The interview takes into account demographic information, medical history, psychological factors, and dietary habits. A nurse will measure blood pressure, weight, height, handgrip, and walking speed. They will also do a simple screen test on cognition, depression, anxiety.”

The study reports that the association between higher mushroom consumption and reduced risk of cognitive decline was “independent of age, gender, education, cigarette smoking, alcohol consumption, hypertension, diabetes, heart disease, stroke, and physical activities.”

Feng said the correlation found in the study was “surprising and encouraging,” adding, “It seems that a commonly available single ingredient could have a dramatic effect on cognitive decline.”

A previous study found that levels of this particular, single ingredient, called ergothioneine (ET), in the plasma of people with MCI were notably lower than healthy people of the same age.

It was this study that fuelled the belief that ET deficiency may contribute to neurodegeneration, and that consuming foods rich in ET, like mushrooms, may help to combat the effects of this particular deficiency.

The ET compound is common to all types of mushrooms studied. Dr. Irwin Cheah, Senior Research Fellow at the NUS Department of Biochemistry explains:

We’re very interested in a compound called ergothioneine (ET). […] ET is a unique antioxidant and anti-inflammatory which humans are unable to synthesise on their own. But it can be obtained from dietary sources, one of the main ones being mushrooms.”

Dr. Irwin Cheah

However, Feng acknowledges that it is not mushrooms alone that can contribute to better cognitive function in older people.

“[…] We are talking about a combination of many factors – tea, green leafy vegetables, nuts and fish are also beneficial,” he explains.

Additionally, some hericenones, erinacines, scabronines, and dictyophorines may be responsible for encouraging nerve growth factors. The bioactive compounds of mushrooms may also be responsible for reducing the risk of cognitive decline by inhibiting beta amyloid production, phosphorylated tau, and acetylcholinesterase.

Dr. James Pickett, head of research at Alzheimer’s Society agrees that there is more to better later-life cognitive health than the number of portions of mushrooms a person eats per week. He expands on the issue, saying:

“There are lots of factors that contribute to the development of dementia and it’s estimated that up to a third of cases could be prevented by changes in lifestyle, including diet.

“Dementia is one of the top 10 causes of death, but people can take action to reduce their risk, so it’s important that we base our advice on consistent evidence that’s built up over multiple studies, and don’t get carried away with the findings of any one single study.”

“So while eating a diet full of fruit and vegetables, including mushrooms, is a great starting point, our best advice is to also cut down on sugar and salt, be physically active, drink in moderation and avoid smoking.”

In the future, Feng and his research team aim to find other dietary factors that help keep the brain healthy in later life and lower the incidence of age-related neurodegeneration.

Randomized trials with the pure ET compound and different plant-based ingredients including L-theanine and catechins from tea leaves could be carried out in the future to prove the efficacy of plant-based chemical compounds in reducing the risk of neurodegeneration, and definitively prove conclusions made about their causal relationship.


Tagged with:

About author

Related Articles